top of page

For a Korean Version of Novo Nordisk to Emerge, We Need to Change This

"Paving the Path to Leadership in Advanced Biotech: A Convergence of Technologies and Government Support"


It was my great pleasure to have a pre-meeting with global prominent scholars to contemplate the requisite socio-cultural milieu that South Korea needs to cultivate should it aspire to create its own equivalent of Novo Nordisk.

We shared intriguing discussions that the key lies in convergence. With a well-established ecosystem of collaboration between academia, industry, and research, a completely new advanced bio-market can be cultivated. Government leadership is of paramount importance. It should be dedicated to fostering talent, strengthening research and development (R&D), and guiding the collaborative efforts between academia and industry.


Yorumlara kapatıldı.
bottom of page